INFECTOPHARM Arzneimittel und Consilium GmbH

4 trials 3 recruiting Commercial sponsor

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

3 Recruiting

1 Completed trials

1 Countries active

4 Unique IMPs

100% Results reported

Phase III

Oversight events:

1 temporary halt across 1 trial

View oversight register →

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Actinic keratosis 1

Top IMPs

PERMETHRIN 2 IVERMECTIN 1 PARAFFIN WHITE SOFT 1 POTASSIUM HYDROXIDE 1

All trials

4 total

5% KOH solution vs placebo treatment of actinic keratosis with different treatment duration Recruiting

2024-514277-21-00 Phase III 1 country POTASSIUM HYDROXIDE
Clinical study on the treatment of scabies disease Recruiting

2024-513288-14-00 Phase III 1 country IVERMECTIN; PERMETHRIN
Scabies therapy with two differently concentrated permethrin creams Recruiting

2023-507925-41-00 Phase III 1 country PERMETHRIN
Study on the prevention of atopic dermatitis symptoms in children with a high risk of the disease through the regular use of a moisturizing … Ended

2024-513289-21-00 Phase III 1 country PARAFFIN WHITE SOFT

Showing 1–4 of 4 trials

← All sponsors A–Z